Position in VTRS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$954,103
+$585,269 QoQ
Shares Held
70,622
+89.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026AXQ CAPITAL, LP holds $3,343,099 across 12 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (28.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
This page
|
70,622 | $954,103 | |
| 2 | COLL |
Collegium Pharmaceutical, Inc
|
17,976 | $594,466 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
38,952 | $370,823 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
18,926 | $350,509 | |
| 5 | ESPR |
Esperion Therapeutics, Inc.
|
94,159 | $257,995 | |
| 6 | AQST |
Aquestive Therapeutics, Inc.
|
47,968 | $199,067 | |
| 7 | EOLS |
Evolus, Inc.
|
47,670 | $195,923 | |
| 8 | EBS |
Emergent BioSolutions Inc.
|
17,004 | $141,133 |
All Filings in VTRS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $954,103 | 70,622 | Shares | Sole | 2026-05-13 | |
| 2025-09-30 | $368,834 | 37,256 | Shares | Sole | 2025-11-10 | |
| 2024-06-30 | $164,446 | 15,470 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $318,798 | 26,700 | Shares | Sole | 2024-05-14 | |
| 2023-03-31 | $162,125 | 16,853 | Shares | Sole | 2023-05-10 | |
| No filing history on record for this holder in this stock. | ||||||